Microbot Medical Inc (NASDAQ:MBOT) saw a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 381,268 shares, a decline of 33.4% from the February 15th total of 572,718 shares. Based on an average daily volume of 236,612 shares, the days-to-cover ratio is currently 1.6 days. Currently, 12.1% of the company’s stock are short sold.

In related news, major shareholder Alliance Investment Management purchased 102,309 shares of the company’s stock in a transaction dated Wednesday, January 16th. The shares were acquired at an average cost of $3.70 per share, with a total value of $378,543.30. Following the completion of the purchase, the insider now owns 302,720 shares of the company’s stock, valued at approximately $1,120,064. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last three months, insiders have acquired 118,362 shares of company stock worth $421,235. Company insiders own 20.31% of the company’s stock.

An institutional investor recently bought a new position in Microbot Medical stock. Geode Capital Management LLC purchased a new position in Microbot Medical Inc (NASDAQ:MBOT) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 22,151 shares of the biotechnology company’s stock, valued at approximately $38,000. Geode Capital Management LLC owned about 0.51% of Microbot Medical at the end of the most recent quarter. Hedge funds and other institutional investors own 5.18% of the company’s stock.

A number of equities analysts have recently weighed in on the stock. LADENBURG THALM/SH SH downgraded shares of Microbot Medical from a “buy” rating to a “hold” rating and set a $1.75 price target on the stock. in a research note on Monday, November 19th. They noted that the move was a valuation call. ValuEngine downgraded shares of Microbot Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, January 15th.

NASDAQ MBOT opened at $8.59 on Friday. Microbot Medical has a 1-year low of $1.38 and a 1-year high of $19.40.

COPYRIGHT VIOLATION NOTICE: “Short Interest in Microbot Medical Inc (MBOT) Decreases By 33.4%” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.thecerbatgem.com/2019/03/17/short-interest-in-microbot-medical-inc-mbot-decreases-by-33-4.html.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.

Read More: What is channel trading?

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.